Recently, via homologous recombination (HR) using CRISPR/Cas9 system, we introduced T315I gatekeeper mutation into the intrinsic BCR::ABL1 fusion gene in human Ph + myeloid leukemia cell lines [19] and Ph + lymphoid leukemia cell line [20]. This evidence concerns the gene BCR and lymphoid leukemia.